Piramal Enterprises Limited (PEL) is one of India’s leading diversified companies, with a presence in Financial Services and Pharmaceuticals. Driven by both organic as well as inorganic strategy, PEL has steered dynamic business growth over the three decades of its existence.

PEL made its foray into the financial services sector with Piramal Capital & Housing Finance Limited (PCHFL), a housing finance company registered with the National Housing Bank (NHB) that is engaged in various financial services businesses. It provides end-to-end financing solutions in both wholesale and retail funding opportunities across sectors such as real estate and infrastructure, renewable energy, hospitality, logistics, industrials, auto components etc. Through its group companies, the platform has strategic partnerships with leading global pension funds such as Canadian Pension Plan Investment Board (CPPIB), APG and Ivanhoe Cambridge.

Products and services offered by the company

Piramal Enterprises Ltd.

Pfizer Ltd.

Ipca Laboratories Ltd.

JB Chemicals & Pharmaceuticals Ltd.

Glaxosmithkline Pharmaceuticals Ltd.

Ajanta Pharma Ltd.

Laurus Labs Ltd.

Sanofi India Ltd.

Alembic Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd.

Suven Pharmaceuticals Ltd.

Aurobindo Pharma Ltd.

Natco Pharma Ltd.

Gland Pharma Ltd.

Eris Lifesciences Ltd.

HDFC Bank Ltd.

ICICI Bank Ltd.

ITC Ltd.

Reliance Industries Ltd.

Tata Motors Ltd.

Market Cap	18,927 Cr		EPS	19.4		High	827.5
Stock P/E	40.9		Net Profit Margin	-90.2		Low	818.55

Open Price	788.1	Volume	4,109
Prev. Close	788.1